Epidiolex Solution
Product Images NDC 70127-100

Product Visual Gallery

This gallery contains 25 technical images submitted to the FDA as part of the official labeling for Epidiolex (NDC 70127-100). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Jazz Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Epidiolex 1

FDA Label Image

9. Screw The Child-resistant Cap Back On The Bottle Tightly By Turning The Cap To The Right (clockwise). (Epidiolex 10)

FDA Label Image

10. Fill A Cup With Warm Soapy Water And Clean The Oral Syringe By Drawing Water In And Out Of The Syringe Using The Plunger. (Epidiolex 11)

FDA Label Image

11. Remove The Plunger From The Barrel Of The Oral Syringe And Rinse Both Parts Under Tap Water. (Epidiolex 12)

FDA Label Image

12. Shake Off Any Extra Water From The Plunger And Oral Syringe Barrel, And Allow Them To Air Dry Until Next Use. (Epidiolex 13)

FDA Label Image

Principal Display Panelndc 70127-100-01epidiolex(cannabidiol) 100 mg/mloral Solution (Epidiolex 14)

FDA Label Image

Principal Display Panelndc 70127-100-10epidiolex(cannabidiol) 100 mg/mloral Solution (Epidiolex 15)

FDA Label Image

Epidiolex 16

FDA Label Image

Epidiolex 17

FDA Label Image

Epidiolex 18

FDA Label Image

Epidiolex 19

FDA Label Image

Epidiolex 2

This text appears to be a graph showing the percentage reduction from baseline in drop seizure frequency for a placebo group and a group given a medication called EPIDIOLEX at a dosage of 20 mg/kg/day. There were 85 participants in the placebo group and 56 in the EPIDIOLEX group. The x-axis seems to show different ranges of drop seizure frequency and the y-axis shows the percentage reduction from baseline. Without further context, it's unclear what study or trial this graph is from.*

FDA Label Image

Epidiolex 20

FDA Label Image

Epidiolex 21

FDA Label Image

Epidiolex 22

FDA Label Image

Epidiolex 23

The text is a label for XEpidiolex, an oral solution containing cannabidiol. It provides instructions for storage, dosage, and use. The solution comes in a 100 mL bottle and includes additional components, such as oral syringes and instructions for use. The label cautions against allowing children to access the medication and advises against freezing the solution. It also notes that the solution contains inactive ingredients such as sesame seed oil, ethanol, and strawberry flavoring. People should not accept the solution if the tamper-evident seal is broken or missing. The label contains a scan code for more information about the product.*

FDA Label Image

Epidiolex 24

This is a label of a 60mL bottle of KEPIIOlEX® which contains 100 mg/mL of cannabidiol. The label provides instructions on storage, stating that the bottle should be kept upright at room temperature and that it should not be frozen. The medication should not be accepted if the ampere-evident seal on the bottle is broken or missing. Additionally, the label instructs pharmacists to dispense the medication to patients with an enclosed medication guide. The usual dose and prescription information is not available. The product is from Greenwich Biosciences, LLC based in Carlsbad, CA.*

FDA Label Image

Epidiolex 25

This is a description of medication called XEpidiolex. It is a cannabidiol that should not be used if the tamper seal on the bottle is missing or broken. The storage instruction advises keeping it out of the reach of children, storing the bottle upright, and discarding the unused portion 12 weeks after first opening. The medication must be stored at controlled room temperature and should not be frozen or refrigerated. The packet contains one 60 mL bottle of XEpidiolex and two bottle adapters along with oral syringes of varying sizes. The ingredients include sesame seed oil, ethanol, sucralose, and strawberry flavoring. The exact dose of medication should be prescribed by a healthcare provider.*

FDA Label Image

Epidiolex 3

This appears to be a table showing the proportion of patients receiving a placebo and different doses of the drug EPIDIOLEX, and the percentage reduction in drop seizure frequency from baseline for each group. The numbers indicate different ranges of percentage reduction.*

FDA Label Image

Epidiolex 4

FDA Label Image

Epidiolex 5

The text describes a table showing the percentage reduction in seizure frequency associated with TSC (Tuberous Sclerosis Complex)-associated seizures in patients receiving EPIDIOLEX compared to patients receiving placebo over a 40-day period. There are several columns and rows indicating the number of patients included in the study and the percentage reduction of seizure frequency in each group.*

FDA Label Image

Epidiolex 6

FDA Label Image

Epidiolex 7

FDA Label Image

Epidiolex 8

These are general syringes for administering the prescribed dosage of Epidiolex-cannabidi. The lot number is provided along with the expiry date which is to be duly noted.*

FDA Label Image

Epidiolex 9

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.